Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Beta Glucan market in this environment.
In terms of revenue, this research report indicated that the global Beta Glucan market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Beta Glucan industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Cargill, Inc aims at producing XX Beta Glucan in 2020, with XX % production to take place in global market, ? ? Tate & Lyle PLC accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Beta Glucan Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Beta Glucan Market?
Cargill, Inc
Tate & Lyle PLC
Kerry Group PLC
Koninklijke DSM N.V.
Frutarom
Garuda International Inc.
Ohly
Milliporesigma
Super Beta Glucan
Lesaffre Human Care
...
Major Type of Beta Glucan Covered in XYZResearch report:
Soluble
Insoluble
Application Segments Covered in XYZResearch Market
Food & Beverages
Personal Care
Pharmaceuticals
Animal Feed
For any other requirements, please feel free to contact us and we will provide you customized report.
Request Sample 
Request Discount 
Inquire Before BuyTable of Contents
Global Beta Glucan Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Soluble -Product Introduction and Major Manufacturers
1.1.2 Insoluble -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Beta Glucan Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Beta Glucan Market
3.1.1 Top Companies leading Beta Glucan Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Beta Glucan Market
3.2.1 Top Companies leading Beta Glucan Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Beta Glucan Market
3.3.1 Top Companies leading Beta Glucan Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Beta Glucan Market
3.4.1 Top Companies leading Beta Glucan Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Beta Glucan Market
3.5.1 Top Companies leading Beta Glucan Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Beta Glucan Market
3.6.1 Top Companies leading Beta Glucan Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Beta Glucan Market
3.7.1 Top Companies leading Beta Glucan Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Beta Glucan Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Beta Glucan Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Beta Glucan Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Beta Glucan Sales and Growth Rate (2021-2026)
5.2 Global Beta Glucan Sales Value and Growth Rate (2021-2026)
6 Beta Glucan Competitive Analysis
6.1 Cargill, Inc
6.1.1 Cargill, Inc Company Profiles
6.1.2 Cargill, Inc Product Introduction
6.1.3 Cargill, Inc Beta Glucan Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Tate & Lyle PLC
6.2.1 Tate & Lyle PLC Company Profiles
6.2.2 Tate & Lyle PLC Product Introduction
6.2.3 Tate & Lyle PLC Beta Glucan Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Kerry Group PLC
6.3.1 Kerry Group PLC Company Profiles
6.3.2 Kerry Group PLC Product Introduction
6.3.3 Kerry Group PLC Beta Glucan Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Koninklijke DSM N.V.
6.4.1 Koninklijke DSM N.V. Company Profiles
6.4.2 Koninklijke DSM N.V. Product Introduction
6.4.3 Koninklijke DSM N.V. Beta Glucan Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Frutarom
6.5.1 Frutarom Company Profiles
6.5.2 Frutarom Product Introduction
6.5.3 Frutarom Beta Glucan Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Garuda International Inc.
6.6.1 Garuda International Inc. Company Profiles
6.6.2 Garuda International Inc. Product Introduction
6.6.3 Garuda International Inc. Beta Glucan Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Ohly
6.7.1 Ohly Company Profiles
6.7.2 Ohly Product Introduction
6.7.3 Ohly Beta Glucan Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Milliporesigma
6.8.1 Milliporesigma Company Profiles
6.8.2 Milliporesigma Product Introduction
6.8.3 Milliporesigma Beta Glucan Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Super Beta Glucan
6.9.1 Super Beta Glucan Company Profiles
6.9.2 Super Beta Glucan Product Introduction
6.9.3 Super Beta Glucan Beta Glucan Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 Lesaffre Human Care
6.10.1 Lesaffre Human Care Company Profiles
6.10.2 Lesaffre Human Care Product Introduction
6.10.3 Lesaffre Human Care Beta Glucan Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 191 |
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 196 |
| Price : US$ 3450 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 194 |
| Price : US$ 3750 | Date : Oct 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 205 |
| Price : US$ 3500 | Date : Sep 2023 |
| Category : Chemicals and Materials | Pages : 152 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
